Despite Concerns About Research Budgets, Genomic Tools and MDx Stocks Rise In 1H 2012 | GenomeWeb

NEW YORK (GenomeWeb News) – While there is widespread concern about potential cutbacks in federal spending for research both in the US and abroad, that concern did little to dampen the stock performance of many of the firms in the GenomeWeb Daily News Index in the first half of 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.